1-3 of 3
Véronique Pascal
Close
Sort by
Journal Articles

NNV024, a Humanized Anti-CD37 Antibody with Enhanced ADCC and Extended Plasma Half-Life for the Treatment of B-Cell Malignancies

Roman Generalov, Elisa Fiorito, Stian Foss, Veronique Pascal, Helen Heyerdahl, Ada Repetto-Llamazares, Jan Terje Andersen, Geir E Tjønnfjord, Sigrid Strand Skånland, Jostein Dahle
Journal: Blood
Blood (2022) 140 (Supplement 1): 3123–3124.
https://doi.org/10.1182/blood-2022-166275
Published: 2022
Journal Articles

B-Cell Targeting Anti-CD37 Humanized Antibodies Engineered for Potent Effector Functions and Extended Plasma Half-Life

Elisa Fiorito, Roman Generalov, Stian Foss, Helen Heyerdahl, Ada Repetto-Llamazares, Veronique Pascal, Geir E Tjønnfjord, Sigrid Strand Skånland, Jan Terje Andersen, Jostein Dahle
Journal: Blood
Blood (2022) 140 (Supplement 1): 6012–6013.
https://doi.org/10.1182/blood-2022-159382
Published: 2022
Journal Articles

Analysis of the linker for activation of T cells and the linker for activation of B cells in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire

Gillian C. Whittaker, Deborah N. Burshtyn, Selinda J. Orr, Laura Quigley, Deborah L. Hodge, Véronique Pascal, Weiguo Zhang, Daniel W. McVicar
Journal: Blood
Blood (2008) 112 (7): 2869–2877.
https://doi.org/10.1182/blood-2007-11-121590
Published: 2008
Includes: Supplemental data